Kathryn Conner, PA
Medical · North Charleston, SCNPI 1811323884
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.4%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Amgen accounts for 72.8% of it on its own, with 26 other manufacturers making up the rest. 2025 is the largest year on record at $5,288, more than ten times the $310 reported in 2021. Among medical clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 110 payments — averaging $65.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$5K
- Radius Health, Inc.$418
- Kyowa Kirin, Inc.$248
- Endo Pharmaceuticals Inc.$237
- Medtronic$186
- AstraZeneca$149
- plus $727 from 21 others
What the payments were for
- Consulting fees$1752%
- Speaking & faculty fees$4,00055%
- Travel & lodging$661%
- Food & beverage$2,97341%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 42 | $5,250 |
| Radius Health, Inc. | 23 | $418 |
| Kyowa Kirin, Inc. | 3 | $248 |
| Endo Pharmaceuticals Inc. | 7 | $237 |
| Medtronic | 2 | $186 |
| AstraZeneca(2 entities) | 3 | $149 |
| Novartis | 3 | $69 |
| Abbott | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Acrotech Biopharma Inc. | 2 | $51 |
| Daiichi Sankyo Inc. | 2 | $51 |
| Merck | 2 | $50 |
| Incyte Corporation | 2 | $50 |
| Integra Lifesciences Corporation | 1 | $34 |
| Sanofi | 1 | $34 |
| Kerecis Limited | 1 | $31 |
| Coherus Oncology, Inc. | 1 | $28 |
| Genentech USA, Inc. | 1 | $28 |
| Ultragenyx Pharmaceutical Inc. | 1 | $26 |
| Tersera Therapeutics LLC | 1 | $25 |
| Puma Biotechnology, Inc. | 1 | $22 |
| Ascendis Pharma Endocrinology Inc | 1 | $22 |
| Sandoz | 1 | $20 |
| Exact Sciences | 1 | $20 |
| Cycle Pharmaceuticals Inc | 1 | $19 |
| Bayer | 1 | $17 |
| GSK | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,214 in reported general payments places this provider in the 90th percentile of 384 medical providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TymlosAbaloparatide | 18 | $58,295 |
| ProliaDenosumab | 24 | $41,864 |
| Risedronate Sodium | 94 | $8,158 |
| Alendronate Sodium | 589 | $5,678 |
| Hydrochlorothiazide | 22 | $64 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Radius Health, Inc.Tymlos | $418 | $58,29518 claims |
| AmgenProlia | $5,250 | $41,86424 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 384 medical providers in South Carolina.
Other medical in North Charleston
- Sierra RoachNorth Charleston$6K
- Carleigh NewmanNorth Charleston$4K
- Christopher ThompsonSpartanburg$78K
- Laura BuchGreenville$73K
- Suzanne SmithWest Columbia$39K
- Stavros ChrysostomidesColumbia$39K
- Ethan CaseySpartanburg$24K
- Jessica HallColumbia$22K
- Mary MacdonaldCharleston$20K
- Cameron PappasGreenville$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.